715 related articles for article (PubMed ID: 29929842)
21. Feasibility and safety of noncontrast percutaneous coronary intervention in patients with complicated acute coronary syndrome.
Higuchi S; Kabeya Y; Nishina Y; Miura Y; Yoshino H
Catheter Cardiovasc Interv; 2020 Dec; 96(7):E666-E673. PubMed ID: 32384577
[TBL] [Abstract][Full Text] [Related]
22. Simplifying contrast-induced acute kidney injury prediction after primary percutaneous coronary intervention: the age, creatinine and ejection fraction score.
Araujo GN; Pivatto Junior F; Fuhr B; Cassol EP; Machado GP; Valle FH; Bergoli LC; Wainstein RV; Polanczyk CA; Wainstein MV
Cardiovasc Interv Ther; 2018 Jul; 33(3):224-231. PubMed ID: 28540634
[TBL] [Abstract][Full Text] [Related]
23. Pre-procedural renal resistive index accurately predicts contrast-induced acute kidney injury in patients with preserved renal function submitted to coronary angiography.
Wybraniec MT; Bożentowicz-Wikarek M; Chudek J; Mizia-Stec K
Int J Cardiovasc Imaging; 2017 May; 33(5):595-604. PubMed ID: 27995343
[TBL] [Abstract][Full Text] [Related]
24. Red cell distribution width predicts contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome.
Kurtul A; Yarlioglues M; Murat SN; Demircelik MB; Acikgoz SK; Ergun G; Duran M; Cetin M; Ornek E
Angiology; 2015 May; 66(5):433-40. PubMed ID: 24834929
[TBL] [Abstract][Full Text] [Related]
25. A simple preprocedural score for risk of contrast-induced acute kidney injury after percutaneous coronary intervention.
Chen YL; Fu NK; Xu J; Yang SC; Li S; Liu YY; Cong HL
Catheter Cardiovasc Interv; 2014 Jan; 83(1):E8-16. PubMed ID: 23907993
[TBL] [Abstract][Full Text] [Related]
26. Risk of contrast-induced nephropathy in patients undergoing complex percutaneous coronary intervention.
Azzalini L; Poletti E; Lombardo F; Laricchia A; Beneduce A; Moscardelli S; Bellini B; Maccagni D; Cappelletti A; Ancona MB; Carlino M; Chieffo A; Colombo A; Montorfano M
Int J Cardiol; 2019 Sep; 290():59-63. PubMed ID: 31005417
[TBL] [Abstract][Full Text] [Related]
27. Elevated homocysteine and the risk of contrast-induced nephropathy: a cohort study.
Barbieri L; Verdoia M; Schaffer A; Niccoli G; Perrone-Filardi P; Bellomo G; Marino P; Suryapranata H; Luca GD
Angiology; 2015 Apr; 66(4):333-8. PubMed ID: 24830422
[TBL] [Abstract][Full Text] [Related]
28. Ultra-Low Contrast Percutaneous Coronary Intervention to Minimize the Risk for Contrast-Induced Acute Kidney Injury in Patients With Severe Chronic Kidney Disease.
Azzalini L; Laricchia A; Regazzoli D; Mitomo S; Hachinohe D; Bellini B; Demir OM; Poletti E; Maccagni D; Colombo A
J Invasive Cardiol; 2019 Jun; 31(6):176-182. PubMed ID: 30865912
[TBL] [Abstract][Full Text] [Related]
29. Urinary renalase concentration in patients with preserved kidney function undergoing coronary angiography.
Wybraniec MT; Bożentowicz-Wikarek M; Chudek J; Mizia-Stec K
Nephrology (Carlton); 2018 Feb; 23(2):133-138. PubMed ID: 27778420
[TBL] [Abstract][Full Text] [Related]
30. Contrast Volume to Glomerular Filtration Ratio and Acute Kidney Injury among ST-Segment Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary Intervention.
Zahler D; Rozenfeld KL; Merdler I; Peri Y; Shacham Y
Cardiorenal Med; 2020; 10(2):108-115. PubMed ID: 31801134
[TBL] [Abstract][Full Text] [Related]
31. Relationship between inflammation and benefits of early high-dose rosuvastatin on contrast-induced nephropathy in patients with acute coronary syndrome: the pathophysiological link in the PRATO-ACS study (Protective Effect of Rosuvastatin and Antiplatelet Therapy on Contrast-Induced Nephropathy and Myocardial Damage in Patients With Acute Coronary Syndrome Undergoing Coronary Intervention).
Toso A; Leoncini M; Maioli M; Tropeano F; Di Vincenzo E; Villani S; Bellandi F
JACC Cardiovasc Interv; 2014 Dec; 7(12):1421-9. PubMed ID: 25523533
[TBL] [Abstract][Full Text] [Related]
32. A prediction model of contrast-associated acute kidney injury in patients with hypoalbuminemia undergoing coronary angiography.
Liu L; Liu J; Lei L; Wang B; Sun G; Guo Z; He Y; Song F; Lun Z; Liu B; Chen G; Chen S; Yang Y; Liu Y; Chen J
BMC Cardiovasc Disord; 2020 Aug; 20(1):399. PubMed ID: 32867690
[TBL] [Abstract][Full Text] [Related]
33. Renal insufficiency following contrast media administration trial III: Urine flow rate-guided versus left-ventricular end-diastolic pressure-guided hydration in high-risk patients for contrast-induced acute kidney injury. Rationale and design.
Briguori C; D'Amore C; De Micco F; Signore N; Esposito G; Napolitano G; Focaccio A;
Catheter Cardiovasc Interv; 2020 Apr; 95(5):895-903. PubMed ID: 31282129
[TBL] [Abstract][Full Text] [Related]
34. Remote Ischemic Conditioning for Preventing Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions/Coronary Angiography: A Meta-Analysis of Randomized Controlled Trials.
Bei WJ; Duan CY; Chen JY; Wang K; Liu YH; Liu Y; Tan N
J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):53-63. PubMed ID: 26112028
[TBL] [Abstract][Full Text] [Related]
35. Elevation of urinary liver-type fatty acid-binding protein as predicting factor for occurrence of contrast-induced acute kidney injury and its reduction by hemodiafiltration with blood suction from right atrium.
Katoh H; Nozue T; Kimura Y; Nakata S; Iwaki T; Kawano M; Kawashiri MA; Michishita I; Yamagishi M
Heart Vessels; 2014 Mar; 29(2):191-7. PubMed ID: 23604313
[TBL] [Abstract][Full Text] [Related]
36. Acute kidney injury following coronary angiography: a nationwide study of incidence, risk factors and long-term outcomes.
Helgason D; Long TE; Helgadottir S; Palsson R; Sigurdsson GH; Gudbjartsson T; Indridason OS; Gudmundsdottir IJ; Sigurdsson MI
J Nephrol; 2018 Oct; 31(5):721-730. PubMed ID: 30187381
[TBL] [Abstract][Full Text] [Related]
37. Echocardiographic correlates of left ventricular filling pressures and acute cardio-renal syndrome in ST segment elevation myocardial infarction patients.
Flint N; Kaufman N; Gal-Oz A; Margolis G; Topilsky Y; Keren G; Shacham Y
Clin Res Cardiol; 2017 Feb; 106(2):120-126. PubMed ID: 27550512
[TBL] [Abstract][Full Text] [Related]
38. Blood Transfusion and the Risk of Acute Kidney Injury Among Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
Karrowni W; Vora AN; Dai D; Wojdyla D; Dakik H; Rao SV
Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582110
[TBL] [Abstract][Full Text] [Related]
39. Contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention without acute left ventricular ejection fraction impairment.
Pyxaras SA; Sinagra G; Mangiacapra F; Perkan A; Di Serafino L; Vitrella G; Rakar S; De Vroey F; Santangelo S; Salvi A; Toth G; Bartunek J; De Bruyne B; Wijns W; Barbato E
Am J Cardiol; 2013 Mar; 111(5):684-8. PubMed ID: 23261003
[TBL] [Abstract][Full Text] [Related]
40. Subclinical and clinical contrast-induced acute kidney injury: data from a novel blood marker for determining the risk of developing contrast-induced nephropathy (ENCINO), a prospective study.
Akrawinthawong K; Ricci J; Cannon L; Dixon S; Kupfer K; Stivers D; Alexander P; David S; McCullough PA
Ren Fail; 2015 Mar; 37(2):187-91. PubMed ID: 25519207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
